Evidence map›Paper›PMID 40971579›Full record

ArticleJMIR formative research2025

Assessing the User Experience of the EU Mobile App for Cancer Prevention: Mixed Methods Study.

Furqan Ahmed, Silvana Romero Saletti, Erica D'Souza, Carolina Espina, David Ritchie, Ana Molina Barceló, Marina Pinto Carbó, Paula Romeo Cervera, Teresa Seum, Hermann Brenner and 9 more

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Furqan AhmedDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology, Achterstraße 30, Bremen, 28359, Germany, 49 42121856913.ORCID 0000-0002-8949-5489
Silvana Romero SalettiPsychological Sciences Research Institute, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0000-0001-7252-8240
Erica D'SouzaInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0002-0744-665X
Carolina EspinaInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0001-6848-4687
David RitchieInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0003-4816-113X
Ana Molina BarcelóCancer and Public Health Research Unit, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain.ORCID 0000-0001-5113-6475
Marina Pinto CarbóCancer and Public Health Research Unit, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain.ORCID 0000-0002-9749-6094
Paula Romeo CerveraCancer and Public Health Research Unit, The Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain.ORCID 0000-0002-5595-240X
Teresa SeumDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.ORCID 0009-0003-4475-0583
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.ORCID 0000-0002-6129-1572
Stephan Van den BrouckePsychological Sciences Research Institute, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.ORCID 0000-0002-9090-8877
Maria KriniPagkyprios Syndesmos Karkinopathon Kai Filon, Paralimni, Cyprus.ORCID 0000-0001-8122-963X
Cristiana FonsecaLiga Portuguesa Contra o Cancro, Lisbon, Portugal.ORCID 0009-0005-6683-9268
Patricia PintoLiga Portuguesa Contra o Cancro, Lisbon, Portugal.ORCID 0009-0007-6496-0552
Diana KrivicAssociation of Slovenian Cancer Societies, Ljubljana, Slovenia.ORCID 0009-0008-7527-0394
Helena Ros ComesanaAssociation of European Cancer Leagues, Brussels, Belgium.ORCID 0009-0002-5247-7073
Wendy YaredAssociation of European Cancer Leagues, Brussels, Belgium.ORCID 0000-0002-0586-1964
Hajo ZeebDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology, Achterstraße 30, Bremen, 28359, Germany, 49 42121856913.ORCID 0000-0001-7509-242X
Tilman BrandDepartment of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology, Achterstraße 30, Bremen, 28359, Germany, 49 42121856913.ORCID 0000-0001-5140-7511

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: In 2022, nearly 20 million new cancer cases and 9.7 million deaths occurred globally. Europe, comprising under 10% of the world's population, accounted for over 22% of cases and 20% of deaths, reflecting an aging population, lifestyle risk factors, and extensive screening. With 40% of cancers preventable through modifiable risk factor interventions, effective prevention is essential. The European Code Against Cancer provides evidence-based guidelines that drive health initiatives across Europe. Supported by Europe's Beating Cancer Plan and the EU4Health program, the EU Mobile App for Cancer Prevention was developed to disseminate these recommendations. However, its effectiveness depends on usability across populations with varying digital and health literacy; this study evaluates the app's usability among diverse European populations. Objective: This study aimed to identify enablers, barriers, and user requirements for the use and maintenance of the English version of the EU Mobile App for Cancer Prevention, focusing on how usability varied across individuals with different levels of digital health literacy and diverse sociodemographic backgrounds. In addition, user feedback on mock wireframes-visual representations of the app's interface and functionality-was gathered to evaluate usability and ease of use, providing insights for tailoring the app design to a broader population. Methods: We conducted a mixed methods study in 7 European countries with 76 adults aged 19-84 years recruited via purposive quota sampling. Participants completed quantitative usability testing using mock wireframes to perform 10 predefined tasks simulating core app functionalities (eg, profile setup and health goal tracking). We recorded task completion time, success rates, self-reported confidence, and perceived difficulty. Digital health literacy was assessed using the eHealth Literacy Scale (eHEALS) scale. Qualitative data were collected through focus group discussions guided by a semistructured interview guide, and transcripts were analyzed via thematic content analysis. Statistical analyses included descriptive statistics and 1-way ANOVA to explore group differences. Results: Overall task completion rates ranged from 75% to 98%, with a median of 86%, indicating general usability. However, usability varied by age, education, and digital health literacy: younger participants and those with higher education and literacy levels reported greater confidence and lower difficulty, whereas older adults and lower-literacy users experienced more challenges. Qualitative analysis identified key themes affecting usability: the need for accessibility (multilingual support and simple language), user-centric design (age-friendly interfaces and intuitive navigation), ethical concerns (data privacy and security), and motivational features (gamification and personalized health goals). Conclusions: The app is generally usable across diverse populations but requires streamlined interfaces and design adaptations to accommodate varying digital health literacy. Ensuring robust data privacy practices is essential for fostering user trust, and integrating motivational elements may enhance sustained engagement. Future work will involve piloting the finalized app to evaluate its real-world uptake and impact on cancer prevention behaviors.

Indexed as

Mobile ApplicationsNeoplasmsAdultAgedEuropeFemaleHealth LiteracyHumansMaleMiddle AgedQualitative ResearchYoung Adultcancer preventiondigital health literacyEuropean Code Against Cancermobile applicationusability testing

Identifiers

PMID40971579
PMCPMC12448259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.